News

March 30, 2017 — New late-breaking featured clinical research presented today adds strong clinical support for Abbott's ...

Home March 30, 2017
Home
News | Defibrillator Monitors

Automated external defibrillators (AEDs) are associated with increased survival of sudden cardiac arrest when installed in schools, yet only 17 out of 50 U.S. states require AED installation in at least some of their schools, according to a new analysis. The analysis was published in the Journal of the American College of Cardiology.

Home March 30, 2017
Home
News | Patient Monitors

Acarix AB recently announced the results from a new multi-center trial of its handheld CADScor System for non-invasive, non-radiation acoustic detection of coronary artery disease (CAD). The results were presented at the American College of Cardiology (ACC) 2017 Annual Scientific Meeting, held March 17-19 in Washington, D.C., and showed the handheld CADScor System rules out CAD with 97 percent negative predictive value. The results confirm the company’s previously announced figures which, prior to this study, were unconfirmed.

Home March 30, 2017
Home
atricure atriclip, LAA occlusion, acc17
Feature | Left Atrial Appendage (LAA) Occluders

March 29, 2017 — For patients with atrial fibrillation (AFib), closing the area of the heart known as the left atrial ...

Home March 29, 2017
Home
Ablation procedure, EP lab, Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation
Feature | Atrial Fibrillation

March 29, 2017 — Uninterrupted treatment with dabigatran (Pradaxa), a non-vitamin K, novel antagonist oral anticoagulant ...

Home March 29, 2017
Home
News | Pharmaceuticals

Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good cholesterol, into the arteries of recent heart attack patients did not reduce the volume of plaque in the arteries compared with placebo injections, according to new research. The findings were presented at the American College of Cardiology’s 66th Annual Scientific Sessions, March 17-19 in Washington, D.C.

Home March 29, 2017
Home
News | Chronic Total Occlusion (CTO) | Dave Fornell

March 29, 2017 — In patients with a complete, persistent arterial blockage, medication alone was found to be equal to ...

Home March 29, 2017
Home
Videos | Cath Lab

MDBuyline analyst Tom Watson shares some of the most important trends in cardiac technology he saw at the 2017 American ...

Home March 28, 2017
Home
News | Defibrillator Monitors

Philips and the U.S. Food and Drug Administration (FDA) announced the company has initiated a recall of its HeartStart MRx Monitor/Defibrillator. The Class I recall is due to electrical and battery connection issues that may prevent the device from powering up, charging and delivering electrical shock therapy. The device may also unexpectedly stop pacing. A delay in delivering therapy could result in serious patient injury such as permanent organ damage, brain injury or death.

Home March 28, 2017
Home
News | Pharmaceuticals

When used as a preventive measure during heart surgery, the heart failure drug levosimendan did not significantly reduce rates of death, heart attack, kidney dialysis or use of a mechanical assist device among patients at high risk for low cardiac output syndrome. These findings were part of a study presented at the American College of Cardiology’s 66th Annual Scientific Session, March 17-19 in Washington, D.C.

Home March 28, 2017
Home
News | Ultrasound Imaging

Young rabbits exposed to ultrasound during fetal development had weaker thighbones than unexposed rabbits, according to a study published in the Pertanika Journal of Science & Technology. While the finding applies to a relatively small group of test subjects, 142 young rabbits, it raises questions about the rising use of prenatal ultrasounds in women worldwide.

Home March 28, 2017
Home
Philips Azurion angiography system, FFR for STEMI
Feature | Cath Lab

March 27, 2017 — Patients experiencing a major heart attack often have more than one clogged artery, but under current ...

Home March 27, 2017
Home
News | Hypertension

Participants in Web-based lifestyle counseling reduced their systolic blood pressure by 10 mmHg, compared with a 6 mmHg reduction for those taking part in a web-based control intervention, a statistically significant difference, according to a new study. The research from this trial — the first randomized, double-blinded trial of an online behavioral intervention for high blood pressure — was presented at the American College of Cardiology’s 66th Annual Scientific Session, March 17-19 in Washington, D.C.

Home March 27, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

Using genetic testing to help personalize warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse events compared with clinically guided dosing, according to new research. Researchers said these findings could have implications for a broad population of patients starting warfarin therapy.

Home March 27, 2017
Home
Videos | Heart Valve Technology

Michael Reardon, M.D., professor of cardiothoracic surgery at Houston Methodist DeBakey Heart and Vascular Center ...

Home March 24, 2017
Home
Subscribe Now